YOLFTbeta
03

Seoulin Bioscience Co.Ltd

038070 · KQ · Healthcare / Biotechnology

3,340.00KRW+45.00 (+1.37%)

Price History

Full chart

Market Stats

Previous Close3,295.00
Open3,370.00
Day Range3,330.00 – 3,450.00
52-Week Range3,600.00 – 7,642.47
Volume7.93K
Market Cap34.88B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield2.57%
Beta0.59
50-Day Avg4,235.30
200-Day Avg5,513.03

About

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOEul-Moon Hwang
  • Employees104
  • Headquarters#A, KOREA BIO PARK, Seongnam-si, South Korea, 463-400, Korea
  • Websitehttps://www.seoulin.co.kr

Leadership

  • Eul-Moon HwangChief Executive Officer
  • MiOk KangChief Executive Officer
  • Ik-Young KimAdvising Director of Technology and Director · b. 1957
  • Nae-Dong KimDirector of Management Counseling and Director · b. 1955
  • Mr. Kul-Yong ChoiDirector of Bio Engineering Business Division and Director · b. 1966

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue42.20B37.66B41.63B44.89B42.62B49.88B54.41B65.09B80.54B104.71B89.57B75.41B77.09B
Growth (%)--10.75%+10.53%+7.83%-5.06%+17.03%+9.09%+19.62%+23.74%+30.01%-14.46%-15.81%+2.23%
Cost of Revenue30.31B24.92B29.93B32.17B29.81B35.43B40.54B48.52B59.44B80.36B69.65B56.43B59.77B
Gross Profit-12.70B11.70B12.72B12.81B14.44B13.86B16.57B21.10B24.35B19.92B18.98B17.32B
Gross Margin-33.72%28.10%28.33%30.05%28.96%25.48%25.45%26.20%23.25%22.24%25.17%22.47%
Operating Expense-10.00B9.95B10.55B11.80B12.70B13.06B12.10B15.06B15.66B19.76B18.88B16.63B
Operating Income4.28B2.70B1.75B2.17B1.00B1.75B800.19M4.47B6.04B8.68B165.54M100.55M691.62M
Operating Margin10.13%7.17%4.21%4.82%2.35%3.50%1.47%6.87%7.51%8.29%0.18%0.13%0.90%
EBITDA---------17.33B1.84B5.25B2.70B
EBITDA Margin---------16.55%2.05%6.96%3.50%
Net Income4.16B2.67B1.83B4.07B2.06B2.62B8.88B4.89B15.59B10.16B-117.55M2.91B731.98M
Net Income Margin9.86%7.08%4.38%9.07%4.84%5.26%16.33%7.52%19.36%9.70%-0.13%3.86%0.95%
R&D1.13B1.07B565.93M795.31M997.98M1.19B954.53M998.37M786.82M870.46M785.23M1.21B935.02M
R&D as % of Total Revenue2.67%2.85%1.36%1.77%2.34%2.39%1.75%1.53%0.98%0.83%0.88%1.61%1.21%
Interest Expense000000018.66M159.01M80.46M16.26M36.83M644.56M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.20%0.08%0.02%0.05%0.84%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets60.39B60.72B66.10B66.47B71.04B71.11B80.71B78.25B136.57B134.87B114.10B101.52B118.80B
Total Liabilities18.82B17.57B20.80B17.87B19.54B17.39B21.00B18.33B61.71B51.08B31.04B17.63B32.75B
Total Equity41.11B42.68B45.30B48.60B51.49B53.72B59.71B59.92B74.86B83.79B83.06B83.89B84.21B
Cash3.87B2.58B3.68B4.80B3.42B3.80B4.54B8.49B160.00K3.26M2.58M2.98M10.45B
Total Debt---2.39B--223.67M521.38M-----
Net Debt--------697.49M8.63B--969.25M

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.94B2.74B4.12B2.76B1.30B4.17B7.32B3.68B8.92B-4.36B930.57M-4.61B4.76B
Investing Cash Flow--881.89M-4.22B3.80B-5.02B364.53M-2.91B708.85M-31.50B-2.67B27.53B6.39B-
Financing Cash Flow2.65B-2.44B1.21B-5.44B2.37B-4.20B-3.70B-402.37M29.01B1.08B-22.78B-7.45B-
Capital Expenditure55.65M761.57M3.74B7.21B8.73B408.02M269.29M401.34M1.67B707.03M974.21M62.42M507.47M
Free Cash Flow-------2.74B7.25B-5.06B-43.65M-4.67B4.25B
Dividends Paid598.00M650.00M675.92M737.13M775.74M644.31M1.03B721.15M769.16M798.49M1.06B836.16M843.60M
FCF to OCF-------74.41%81.28%116.23%-4.69%101.35%89.34%
Dividend Paid to FCF-------26.30%10.61%-15.77%-2434.27%-17.89%19.84%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Aug 14, 2015Nov 13, 2015Feb 25, 2016May 15, 2016Aug 12, 2016Nov 15, 2016Mar 3, 2017May 12, 2017Aug 11, 2017Nov 10, 2017Feb 20, 2018May 14, 2018Aug 13, 2018Nov 13, 2018Feb 25, 2019May 15, 2019Aug 13, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual2.8889.7687.51174.20125.2773.91128.57136.88178.97169.62119.01144.28153.90139.9148.37112.0182.6725.1598.0842.05101.93-10.9268.8736.28272.5433.07123.18112.2370.2632.8128.2849.0089.74102.7767.7151.07825.71143.6793.57110.00123.10145.32171.36165.04184.061455.22-72.60228.88325.37-107.6332.72201.226.4062.80-283.5263.0291.9954.95119.6642.66-31.5686.89-57.8818.48-52.76
Surprise-----------------------------------------------------------------
Timing--------------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market----------------------------

Key Statistics & Ratios

Market Cap34.88B
Enterprise Value17.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.42
Price / Book0.42
Revenue (TTM)83.17B
Gross Profit (TTM)17.75B
EBITDA1.69B
Profit Margin1.10%
Operating Margin-2.87%
Return on Equity0.99%
Return on Assets0.28%
Shares Outstanding8.82M
Shares Float6.21M
Beta0.59
Dividend Yield2.57%
Dividend Rate100.00
Payout Ratio310.30%

Dividends

20251×
100.00Dec 29, 2025
20241×
97.73Dec 27, 2024
20231×
95.47Dec 27, 2023
20221×
121.21Dec 28, 2022
20211×
91.01Dec 29, 2021
20201×
88.79Dec 29, 2020
20191×
85.46Dec 27, 2019
20181×
79.92Dec 27, 2018
20171×
75.53Dec 27, 2017
20161×
92.45Dec 28, 2016
20151×
88.03Dec 29, 2015
20141×
83.60Dec 29, 2014
20131×
79.04Dec 27, 2013
20121×
76.00Dec 27, 2012
20111×
69.92Dec 28, 2011
20101×
50.05Dec 29, 2010
20091×
46.32Dec 29, 2009
20081×
55.37Dec 29, 2008
20071×
63.89Dec 27, 2007
20061×
55.37Dec 27, 2006
20051×
42.59Dec 28, 2005

Stock Splits

  • Dec 29, 2025662:647
  • Dec 27, 20241684:1645
  • Dec 27, 2023899:878
  • Dec 28, 2022628:613
  • Dec 29, 20211637:1597
  • Dec 29, 2020959:923
  • Dec 27, 2019401:375
  • Dec 27, 2018401:379
  • Dec 27, 20171112:1047
  • Dec 28, 20161149:1094
  • Dec 29, 20152010:1909
  • Dec 29, 201455:52
  • Dec 27, 201326:25
  • Dec 27, 201225:23
  • Dec 28, 20111398:1301
  • Dec 29, 2010939:869
  • Dec 29, 20093191:2934